Simplified Chinese

English

Home page

District leaders visit enterprises for research, closely monitoring Minhai’s development.

Release date:

2018-05-25

Author:

Contributed by the Marketing Department

Source:

Abstract

In recent years, Minhai Biotechnology has experienced rapid growth, with increased investment in technological innovation, talent development, and structural adjustments, yielding significant results. The company’s core competitiveness has steadily strengthened, and it has earned a strong reputation within China’s vaccine industry. These achievements are attributable to the company’s sound strategic decisions, as well as the unwavering support and guidance of the Daxing District Party Committee and government. Recently, several district leaders visited Minhai Biotechnology for on-site inspections and research, offering full recognition of the company’s accomplishments.

　　In recent years, Minhai Biotechnology has achieved rapid and robust growth, with substantial investments in technological innovation, talent development, and structural adjustments, yielding significant results. The company’s core competitiveness has continued to strengthen, and it has earned a strong reputation within China’s vaccine industry. These accomplishments are the result of the company’s sound strategic decisions, as well as the unwavering support and guidance from the Daxing District Party Committee and government. Recently, several district leaders visited Minhai Biotechnology for on-site inspections and research, offering full recognition of the company’s achievements.

　　On the morning of May 14, 2018, Jin Weidong, Member of the Standing Committee of the CPC Daxing District Committee and Head of the United Front Work Department, along with Song Shiming, Deputy Secretary of the Party Working Committee of the Biomedical Base and General Manager of the company, and other leaders, paid a visit to our company for research and inspection. Zheng Haifa, General Manager of the company, Liu Jiankai, Executive Deputy General Manager, and heads of relevant departments accompanied them on a tour of Minhai’s Vaccine R&D Center and held an exchange meeting with Minhai’s leading talents and representatives of its high‑tech workforce.

　　At the meeting, General Manager Zheng provided a detailed overview of the company’s overall situation and reported on the land-use planning and proposed development for Minhai Phase II. Following the briefing, Standing Committee Member Jin commended Minhai Bio’s research achievements, expressed strong support for the company’s growth, offered policy guidance, and pledged timely assistance in addressing any challenges it faces. Subsequently, Secretary Song stated that the Management Committee will continue to provide steadfast support and services to enterprises, further enhancing Minhai Bio’s core competitiveness.

　　Following the symposium, Jin, a member of the Standing Committee and a leader in Daxing District, stated that the Daxing District Party Committee and government will provide strong support to technology‑innovation enterprises like Minhai Biotechnology. He expressed the hope that the company will continue to develop and produce even better vaccines, benefiting humanity. He also urged Minhai Biotechnology, amid a highly competitive market environment, to attract and retain top talent, pursue efficient innovation, and swiftly translate scientific and technological advances into practical applications, thereby making an even greater contribution to local economic development.

Keywords:

Minhai Biotechnology has been honored with the national “Ankang Cup” competition’s title of Outstanding Collective.

Liu Jiankai Innovation Studio of Minhai Biotechnology has been awarded the “National Model Worker Team” title.

Recommended Reading

Batch Release Status of the Company’s Products in 2026

The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.

Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.

Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09

Online Customer Service

Telephone

400 189 9806

Contact Information

Customer Service Hotline

4001899806

Phone number

010-59613600

Official Website

http://www.biominhai.com

Company Address

No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing

WeChat Official Account

Business license

Website Development: China Enterprise Dynamics

Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.